PS-031291

N/A

Report date: 2025/02/01 20:00:06
NME

Base Information

Drug NamePS-031291
Drug Alias NameCCR1 antagonists (Ligand)CCR1 antagonists (Pharmacopeia)PS-031291
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionC-C chemokine receptor type 1 antagonists
TargetsC-C chemokine receptor type 1
Therapy Area/IndicationsInflammationMultiple Myeloma
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesPharmacopeia Llc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesPharmacopeia LlcLigand Pharmaceuticals Inc
Active IndicationsN/A
Inactive IndicationsInflammationMultiple Myeloma

Other Information

ATC CodeN/A
Related LinksN/A